Origin and Proliferation of Multiple-Drug Resistance in Bacterial Pathogens
暂无分享,去创建一个
Yonatan H. Grad | Marc Lipsitch | Ted Cohen | William P. Hanage | Hsiao-Han Chang | Thomas F. O'Brien | M. Lipsitch | W. Hanage | Y. Grad | T. Cohen | Hsiao-Han Chang | T. O'Brien
[1] A. Lalvani,et al. Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. , 2013, Emerging infectious diseases.
[2] Eduardo Gotuzzo,et al. Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.
[3] R. Dagan,et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media , 2000, The Pediatric infectious disease journal.
[4] R. Hall. Integrons and gene cassettes: hotspots of diversity in bacterial genomes , 2012, Annals of the New York Academy of Sciences.
[5] F. Milner,et al. Disease Control , 2005, Fertility, Food and Fever.
[6] A. Coates,et al. Novel classes of antibiotics or more of the same? , 2011, British journal of pharmacology.
[7] F. Taddei,et al. The rise and fall of mutator bacteria. , 2001, Current opinion in microbiology.
[8] M. Bonten,et al. Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance. , 2006, Current opinion in microbiology.
[9] John P. Huelsenbeck,et al. A Phylogenetic Model for the Detection of Epistatic Interactions , 2013, Molecular biology and evolution.
[10] Alexandros Stamatakis,et al. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies , 2014, Bioinform..
[11] M. Unemo,et al. Current and future treatment options for gonorrhoea , 2013, Sexually Transmitted Infections.
[12] J. Parkhill,et al. The Impact of Recombination on dN/dS within Recently Emerged Bacterial Clones , 2011, PLoS pathogens.
[13] V. Bidnenko,et al. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Sousa,et al. Positive Epistasis Drives the Acquisition of Multidrug Resistance , 2009, PLoS genetics.
[15] J. Miller,et al. Proliferation of mutators in A cell population , 1997, Journal of bacteriology.
[16] Sebastian Bonhoeffer,et al. Cycling Empirical Antibiotic Therapy in Hospitals: Meta-Analysis and Models , 2014, PLoS pathogens.
[17] E. Akl,et al. Periodic presumptive treatment of curable sexually transmitted infections among sex workers: a systematic review , 2012, AIDS.
[18] J. Corander,et al. Bayesian identification of admixture events using multilocus molecular markers , 2006, Molecular ecology.
[19] Gary D Bader,et al. Global Mapping of the Yeast Genetic Interaction Network , 2004, Science.
[20] S. Levy,et al. Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.
[21] Ted Cohen,et al. Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy , 2011, PloS one.
[22] G. Stefánsdóttir,et al. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study , 1996, BMJ.
[23] P. V. van Helden,et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. , 2005, American journal of respiratory and critical care medicine.
[24] M. Kimura. Evolutionary Rate at the Molecular Level , 1968, Nature.
[25] Chun-Yu Lin,et al. Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[26] P. Bradford. Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat , 2001, Clinical Microbiology Reviews.
[27] M. E. Palmer,et al. The Influence of Hitchhiking and Deleterious Mutation Upon Asexual Mutation Rates , 2006, Genetics.
[28] R. Lacey,et al. DOUBLE-BLIND STUDY TO COMPARE THE SELECTION OF ANTIBIOTIC RESISTANCE BY AMOXYCILLIN OR CEPHRADINE IN THE COMMENSAL FLORA , 1983, The Lancet.
[29] F. Baquero,et al. Geographical and Ecological Analysis of Resistance, Coresistance, and Coupled Resistance to Antimicrobials in Respiratory Pathogenic Bacteria in Spain , 2005, Antimicrobial Agents and Chemotherapy.
[30] H. Goossens,et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.
[31] Marc Lipsitch,et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States , 2003, Nature Medicine.
[32] R. Lenski,et al. Pervasive joint influence of epistasis and plasticity on mutational effects in Escherichia coli , 2004, Nature Genetics.
[33] C. Dye,et al. Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .
[34] J. Burton,et al. Rapid Pneumococcal Evolution in Response to Clinical Interventions , 2011, Science.
[35] D. Hartl,et al. Principles of population genetics , 1981 .
[36] J. Salomon,et al. Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation , 2012, PLoS medicine.
[37] Victor DeGruttola,et al. Bayesian Estimation of Mixture Models with Prespecified Elements to Compare Drug Resistance in Treatment-Naïve and Experienced Tuberculosis Cases , 2013, PLoS Comput. Biol..
[38] K. Boye,et al. Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus in Iceland from 2000 to 2008: a Challenge to Current Guidelines , 2010, Journal of Clinical Microbiology.
[39] P. Smouse,et al. genalex 6: genetic analysis in Excel. Population genetic software for teaching and research , 2006 .
[40] D. Mitchison. The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems. , 1992, The Journal of antimicrobial chemotherapy.
[41] S. Harbarth,et al. At least it won't hurt: the personal risks of antibiotic exposure. , 2011, Current opinion in pharmacology.
[42] D. Greenberg,et al. Community Prescribing and Resistant Streptococcus pneumoniae , 2005, Emerging infectious diseases.
[43] Fernando Baquero,et al. Selection of Naturally Occurring Extended-Spectrum TEM β-Lactamase Variants by Fluctuating β-Lactam Pressure , 2000, Antimicrobial Agents and Chemotherapy.
[44] J. Tapsall. Multidrug-resistant Neisseria gonorrhoeae , 2009, Canadian Medical Association Journal.
[45] Peter Mullany,et al. A modular master on the move: the Tn916 family of mobile genetic elements. , 2009, Trends in microbiology.
[46] J. Papp,et al. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006–June 2012 , 2013, Sexually Transmitted Infections.
[47] T. Shimao. Drug resistance in tuberculosis control. , 1987, Tubercle.
[48] S. Wahlund. ZUSAMMENSETZUNG VON POPULATIONEN UND KORRELATIONSERSCHEINUNGEN VOM STANDPUNKT DER VERERBUNGSLEHRE AUS BETRACHTET , 2010 .
[49] S. Weis,et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. , 1994, The New England journal of medicine.
[50] Marc Lipsitch,et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug resistant tuberculosis , 2013, Nature Genetics.
[51] G. Smith,et al. Rapid single-colony whole-genome sequencing of bacterial pathogens , 2013, The Journal of antimicrobial chemotherapy.
[52] E. Holmes,et al. Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[53] D. Mitchison. Understanding the chemotherapy of tuberculosis—current problems , 1992 .
[54] Hermann J. Muller,et al. Evolution by mutation , 1958 .
[55] Jinliang Wang. Maximum-likelihood estimation of admixture proportions from genetic data. , 2003, Genetics.
[56] D. Hooper,et al. Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study. , 2014, The Journal of antimicrobial chemotherapy.
[57] E. Lesho,et al. Characteristics of Plasmids in Multi-Drug-Resistant Enterobacteriaceae Isolated during Prospective Surveillance of a Newly Opened Hospital in Iraq , 2012, PloS one.
[58] D. Livermore,et al. Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. , 2005, The Journal of antimicrobial chemotherapy.
[59] S. Fridkin. Routine cycling of antimicrobial agents as an infection-control measure. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] W. Bishai,et al. Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor. , 2013, American journal of respiratory and critical care medicine.
[61] H. Wexler,et al. Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates. , 2006, The Journal of antimicrobial chemotherapy.
[62] H. Berger,et al. Selective allele loss in mixed infections with T4 bacteriophage. , 1973, Genetics.
[63] Dirk Vogelaers,et al. The rising problem of antimicrobial resistance in the intensive care unit , 2011, Annals of intensive care.
[64] M. Pai,et al. Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis , 2008, Annals of Internal Medicine.
[65] S WRIGHT,et al. Genetical Structure of Populations , 1950, British medical journal.
[66] F. Taddei,et al. Second-order selection in bacterial evolution: selection acting on mutation and recombination rates in the course of adaptation. , 2001, Research in microbiology.
[67] Jukka Corander,et al. Dense genomic sampling identifies highways of pneumococcal recombination , 2014, Nature Genetics.
[68] Jukka Corander,et al. Bayesian modeling of recombination events in bacterial populations , 2008, BMC Bioinformatics.
[69] M. Pichichero,et al. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. , 2007, JAMA.
[70] P. Nordmann,et al. Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.
[71] Carlos G. Grijalva,et al. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. , 2009, JAMA.
[72] S. Lemon,et al. Forum on Microbial Threats , 2020 .
[73] B. Fantin,et al. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. , 2009, The Journal of infectious diseases.
[74] D. Low,et al. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[75] E. Graviss,et al. Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study. , 2013, The Lancet. Infectious diseases.
[76] Po Ughachukwu,et al. Efflux Pump-Mediated Resistance in Chemotherapy , 2012, Annals of medical and health sciences research.
[77] Matthew H Samore,et al. Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. , 2006, American journal of epidemiology.
[78] Jacqueline A. Keane,et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins , 2014, Nucleic acids research.
[79] W. Shafer,et al. Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations. , 2012, Journal of Infectious Diseases.
[80] E. Leigh,et al. The evolution of mutation rates. , 1973, Genetics.
[81] W. L. Payne,et al. High Mutation Frequencies Among Escherichia coli and Salmonella Pathogens , 1996, Science.
[82] Rafael Sanjuán,et al. The contribution of epistasis to the architecture of fitness in an RNA virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[83] D. Falush,et al. Inference of Bacterial Microevolution Using Multilocus Sequence Data , 2007, Genetics.
[84] D. Reich,et al. Population Structure and Eigenanalysis , 2006, PLoS genetics.
[85] L. Cui,et al. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus , 2006, Antimicrobial Agents and Chemotherapy.
[86] B. Weir,et al. ESTIMATING F‐STATISTICS FOR THE ANALYSIS OF POPULATION STRUCTURE , 1984, Evolution; international journal of organic evolution.
[87] J. Carlet. The gut is the epicentre of antibiotic resistance , 2012, Antimicrobial Resistance and Infection Control.
[88] M. Lipsitch,et al. Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children , 2009, Pediatrics.
[89] J. Palomino,et al. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. , 2011, The Journal of antimicrobial chemotherapy.
[90] R. Kishony,et al. Functional classification of drugs by properties of their pairwise interactions , 2006, Nature Genetics.
[91] Jody Hey,et al. Principles of population genetics (2nd edn) , 1989 .
[92] R. MacLean,et al. The cost of multiple drug resistance in Pseudomonas aeruginosa , 2009, Journal of evolutionary biology.
[93] P. Farmer,et al. Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. , 2012, Bulletin of the World Health Organization.
[94] C. Carlier,et al. Transposable multiple antibiotic resistance in Streptococcus pneumoniae , 1986, Molecular and General Genetics MGG.
[95] M. Lipsitch,et al. Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States. , 2013, The Journal of infectious diseases.
[96] L. Peixe,et al. Co-transfer of resistance to high concentrations of copper and first-line antibiotics among Enterococcus from different origins (humans, animals, the environment and foods) and clonal lineages. , 2014, The Journal of antimicrobial chemotherapy.
[97] Leigh Eg,et al. The evolution of mutation rates. , 1973 .
[98] G. Dougan,et al. Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology , 2012, PLoS pathogens.
[99] Carl T. Bergstrom,et al. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[100] Diarmaid Hughes,et al. Antibiotic resistance and its cost: is it possible to reverse resistance? , 2010, Nature Reviews Microbiology.
[101] D. Livermore,et al. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction , 2001, The Lancet.
[102] K. Poole. Efflux-mediated antimicrobial resistance. , 2005, The Journal of antimicrobial chemotherapy.
[103] P. Donnelly,et al. Inference of population structure using multilocus genotype data. , 2000, Genetics.
[104] David N. Reshef,et al. Factors Related to Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobial Drugs in Neisseria gonorrhoeae, United States , 2012, Emerging infectious diseases.
[105] H. Nikaido,et al. Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis , 2004, Antimicrobial Agents and Chemotherapy.
[106] M. Haber,et al. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[107] Julian Parkhill,et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study , 2014, The Lancet. Infectious diseases.
[108] M. DePristo,et al. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. , 2010, Molecular cell.
[109] P. Lu,et al. Characterization of Fluoroquinolone Resistance Mechanisms and Their Correlation with the Degree of Resistance to Clinically Used Fluoroquinolones among Escherichia coli Isolates , 2007, Journal of chemotherapy.
[110] J. Wasserheit,et al. The emerging threat of untreatable gonococcal infection. , 2012, The New England journal of medicine.
[111] L. Ng,et al. Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario , 2009, Canadian Medical Association Journal.
[112] C. Whitney,et al. Levofloxacin-Resistant Invasive Streptococcus pneumoniae in the United States: Evidence for Clonal Spread and the Impact of Conjugate Pneumococcal Vaccine , 2004, Antimicrobial Agents and Chemotherapy.
[113] Ziheng Yang. PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.
[114] S. Dowell,et al. Holiday spikes in pneumococcal disease among older adults. , 2009, The New England journal of medicine.
[115] Russell B. Corbett-Detig,et al. Genetic Incompatibilities are Widespread Within Species , 2013, Nature.
[116] A O Summers,et al. Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates , 1993, Antimicrobial Agents and Chemotherapy.
[117] J. Dushoff,et al. Prevalence of Epistasis in the Evolution of Influenza A Surface Proteins , 2011, PLoS genetics.
[118] F. Baquero,et al. Antibiotic-selective environments. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[119] J. Gerberding,et al. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. , 2005, MMWR. Morbidity and mortality weekly report.
[120] Jukka Corander,et al. Hyper-Recombination, Diversity, and Antibiotic Resistance in Pneumococcus , 2009, Science.
[121] S. Gorbach,et al. Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic , 2013, Annals of the New York Academy of Sciences.
[122] Richard Colgan,et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[123] J. Pagés,et al. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. , 2009, Biochimica et biophysica acta.
[124] Marc Lipsitch,et al. Epidemiologic data and pathogen genome sequences: a powerful synergy for public health , 2014, Genome Biology.
[125] S. Solomon,et al. Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.
[126] R. Lenski. Quantifying fitness and gene stability in microorganisms. , 1991, Biotechnology.
[127] P. V. van Helden,et al. Mycobacterium tuberculosis Beijing genotype: a template for success. , 2011, Tuberculosis.
[128] David A. Relman,et al. Antibiotic resistance : implications for global health and novel intervention strategies : workshop summary , 2010 .
[129] J. Rood,et al. Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants , 1999, Antimicrobial Agents and Chemotherapy.
[130] 熊礼宽,et al. Mycobacterium , 1977, Bacteriological reviews.
[131] B. Levin,et al. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[132] M. Lipsitch,et al. Population genomics of post-vaccine changes in pneumococcal epidemiology , 2013, Nature Genetics.